Tumor Response to Irinotecan is Associated with IL-10 Expression Level in Metastatic Colorectal Cancer-Results from mCRC Biomarker Study.
Jinjia ChangWen ZhangGuangyi LinDuo TongDan ZhuJing ZhaoQihe YuDan HuangWenhua LiPublished in: OncoTargets and therapy (2020)
Our study demonstrated that IL-10 could act as a prognostic biomarker for mCRC patients undergoing irinotecan-containing chemotherapy.